You are here: Industry Insights > Gland Pharma

News List

Gland Pharma launches of the first non-frozen ready-to-use Bivalirudin expresspharma
June 09, 2020
Bivalirudin RTU Injection is indicated for use as an anticoagulant in patients undergoing percutaneous coronary intervention.
China’s Fosun Pharma takeover of an Indian pharma giant biospectrumasia
October 27, 2017
The deal will help the Chinese company make inroads into India, gain access to US injectable drug market where Gland has a firm hold and bolster its product portfolio
Fosun Pharma acquires 74 per cent stake in Gland Pharma for $1.09 bn expressbpd
October 09, 2017
Chinese drug firm Fosun Pharma has acquired approximately 74 per cent in Hyderabad-based Gland Pharma at a valuation of not more than $1.09 billion, the company has said.
Fosun pharma cuts stake to 74 % in Gland Pharma deal biospectrumasia
September 20, 2017
Following the amendment, the deal no longer needs approval from the India Foreign Investment Promotion Board and the Cabinet Committee on Economic Affairs of India
Fosun Pharma to acquire 74 per cent stake in Gland Pharma expressbpd
September 19, 2017
In a filing on Hong Kong, S.A.R., China stock exchange, Shanghai Fosun Pharmaceutical Group said the relevant parties have entered into certain amendments to the transaction documents
China's Fosun Group acquired 74% stake in Gland Pharma for $1.1 billion pharmafile
September 19, 2017
Fosun has sealed the deal of acquiring 74% of India’s Gland Pharma for $1.1 billion.
Indian govt may turn down Fosun's offer to acquire Gland Pharma biospectrumasia
August 02, 2017
The deal, if materializes will be China’s biggest takeover of Indian company